Fourth quarter revenues increased 116% to $91.1 million versus fourth quarter of 2023Full year revenues increased 473% to $290.5 million versus ...

Lilly is testing bimagrumab alone and in combination with Novo's Wegovy -- a mid-stage trial begun before the acquisition -- ...

Some doctors say drugs that improve muscle mass could benefit older or infirm people at greater risk of falls and fractures.

Fund Of The Week quizzes fund managers about how they’re investing your money. If you’d like to suggest which funds you want ...

DNA hydrogels are biocompatible drug delivery systems for targeted therapeutic interventions. Conventional DNA hydrogels, formed with many DNA nanostructure units, lead to increased preparation costs ...

To determine the findings, the publication surveyed more than 217,000 employees and asked if they would recommend their ...

To determine the findings, the publication surveyed more than 217,000 employees and asked if they would recommend their company as well as to rate their firm based on criteria including salary, work ...

In exchange for $165 million, Biogen now has access to zorevunersen, a potential first-of-its-kind treatment for Dravet ...

Stoke Therapeutics Inc. (Nasdaq: STOK) has pulled in Biogen (Nasdaq: BIIB) to help it develop and commercialize a treatment ...

The biotech industry is on a stable growth path, owing to the integration of modern technologies and rapid drug discoveries.

Biogen and Stoke Therapeutics have signed a deal to co-develop and sell Stoke’s experimental drug for Dravet syndrome, ...

A student of a government college here has made allegations of brutal ragging, claiming that he was targeted by senior ...